A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
2020
Signal Transduction and Targeted Therapy
Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma of the head and neck region which mainly distributes in southern China and Southeast Asia and has a crucial association with the Epstein–Barr virus. Based on epidemiological data, both incidence and mortality of NPC have significantly declined in recent decades grounded on the improvement of living standard and medical level in an endemic region, in particular, with the clinical use of individualized chemotherapy and
doi:10.1038/s41392-020-00340-2
pmid:33093441
fatcat:6cd443e3ibfdxlmxa7bh6m24i4